1. Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Will Allosource be the final straw to bring down Nuva?

Discussion in 'NuVasive' started by Anonymous, Oct 29, 2012 at 10:06 AM.

  1. Anonymous

    Anonymous Guest

    2002 the FDA hammered down on Allosource for having a very dirty facility and body tissue/parts heavily contaminated.


    If you look up Allosource on MAUDE only 1 single report comes up. Yet in 2006 there was a big recall of body parts by Allosource:


    No real enforcement action has been done the last few years to create jobs/money. With the Fed's hurting for money the little voice in my head is saying the Fed's are going to hammer down soon.

    Anybody think if Allosource going down it will greatly impact Nuvasive as well? The material getting put inside Nuvasives spine spacer, has any of that material came from Allosource over the years?

    I see they have a joint deal going on. Maybe some inside voices can tell us what we're going to be reading in the papers in the coming months??